Earnings4572Carna Biosciences,Inc.
Carna Biosciences Reports Q1 Revenue of 180 million, Up 28%
TOKYO, May 08 (Pulse News Wire) – Carna Biosciences, Inc. (4572.T) reported consolidated results for Q1 FY2026 (ending December 2026). Revenue was ¥180 million (+28.1% YoY). operating profit was ¥458 m
TOKYO, May 08 (Pulse News Wire) – Carna Biosciences, Inc. (4572.T) reported consolidated results for Q1 FY2026 (ending December 2026).
Revenue was ¥180 million (+28.1% YoY). operating profit was ¥458 million.
Net profit was ¥513 million. Total assets stood at ¥1.2 billion with an equity ratio of 25.1%.
The full-year forecast for the current fiscal year is revenue of ¥720 million (+24.4%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥183M | +28.1% |
| Operating profit | ¥-458M | -488.0% |
| Net profit | n/a | n/a |
Next period forecast
Revenue
¥720M
+24.4%Op. profit
¥-2,028M
-2053.0%Source: TDNet filing · Figures in millions of yen
End of article